Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study
The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16...
Saved in:
Published in | Journal of neurology Vol. 263; no. 7; pp. 1323 - 1331 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.07.2016
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell–inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1–45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (−1.1 µm, 95 % CI 1.4–0.7,
p
< 0.001) and mGCIPL (−1.1 µm, 95 % CI −1.4 to −0.8,
p
< 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (−0.03 µm, 95 % CI −0.2 to 0.2,
p
= 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury. |
---|---|
AbstractList | The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell–inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1–45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (−1.1 µm, 95 % CI 1.4–0.7,
p
< 0.001) and mGCIPL (−1.1 µm, 95 % CI −1.4 to −0.8,
p
< 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (−0.03 µm, 95 % CI −0.2 to 0.2,
p
= 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury. The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1-45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (-1.1 µm, 95 % CI 1.4-0.7, p < 0.001) and mGCIPL (-1.1 µm, 95 % CI -1.4 to -0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (-0.03 µm, 95 % CI -0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury. The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1-45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (-1.1 µm, 95 % CI 1.4-0.7, p < 0.001) and mGCIPL (-1.1 µm, 95 % CI -1.4 to -0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (-0.03 µm, 95 % CI -0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury.The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1-45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (-1.1 µm, 95 % CI 1.4-0.7, p < 0.001) and mGCIPL (-1.1 µm, 95 % CI -1.4 to -0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (-0.03 µm, 95 % CI -0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury. The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1-45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (-1.1 µm, 95 % CI 1.4-0.7, p < 0.001) and mGCIPL (-1.1 µm, 95 % CI -1.4 to -0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (-0.03 µm, 95 % CI -0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury. The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1-45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (-1.1 mu m, 95 % CI 1.4-0.7, p < 0.001) and mGCIPL (-1.1 mu m, 95 % CI -1.4 to -0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (-0.03 mu m, 95 % CI -0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury. |
Author | Cruz-Herranz, Andrés Petzold, Axel Arnow, Sam Tewarie, Prejaas Killestein, Joep Gelfand, Jeffrey M. Green, Ari J. Balk, Lisanne J. Albrecht, Philipp Uitdehaag, Bernard M. J. |
Author_xml | – sequence: 1 givenname: Lisanne J. surname: Balk fullname: Balk, Lisanne J. email: l.balk@vumc.nl organization: Department of Neurology, MS Centre, VU University Medical Center – sequence: 2 givenname: Andrés surname: Cruz-Herranz fullname: Cruz-Herranz, Andrés organization: Department of Neurology, University of California San Francisco – sequence: 3 givenname: Philipp surname: Albrecht fullname: Albrecht, Philipp organization: Department of Neurology, Heinrich-Heine University – sequence: 4 givenname: Sam surname: Arnow fullname: Arnow, Sam organization: Department of Neurology, University of California San Francisco – sequence: 5 givenname: Jeffrey M. surname: Gelfand fullname: Gelfand, Jeffrey M. organization: Department of Neurology, University of California San Francisco – sequence: 6 givenname: Prejaas surname: Tewarie fullname: Tewarie, Prejaas organization: Department of Neurology, MS Centre, VU University Medical Center – sequence: 7 givenname: Joep surname: Killestein fullname: Killestein, Joep organization: Department of Neurology, MS Centre, VU University Medical Center – sequence: 8 givenname: Bernard M. J. surname: Uitdehaag fullname: Uitdehaag, Bernard M. J. organization: Department of Neurology, MS Centre, VU University Medical Center – sequence: 9 givenname: Axel surname: Petzold fullname: Petzold, Axel organization: Department of Neurology, MS Centre, VU University Medical Center, Moorfields Eye Hospital, UCL Institute of Neurology – sequence: 10 givenname: Ari J. surname: Green fullname: Green, Ari J. organization: Department of Neurology, University of California San Francisco |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27142714$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUtP3DAUha0KVGZof0A3VSQ23QSuE8ePLpDQiKeoWHS6tjyOPTXK2NROKubf48xABUhULCz76n7n6PqeKdrxwRuEvmA4xADsKAEQ3JSAaclxxcr1BzTBpK5KTBqxgyZQEyibuiF7aJrSLQDw3PiI9iqGyXgm6GruVs4vi2CLaHrnVVd4M8QwPpRvC3W_eXYhpcL54sfP74XKlV-6fmg3-M1sXqRcrD-hXau6ZD4_3vvo19npfHZRXt-cX85OrkvdQN2XiwVWXAkramYr3dSWWWMIsZoTzrkmgraMW0brtuILaDgmynIBBogArlte76Pjre_dsFiZVhvfR9XJu-hWKq5lUE6-7Hj3Wy7DX0lEJTCDbPDt0SCGP4NJvVy5pE3XKW_CkCTmwFnFCKXvQfMmqWhYRg9eobdhiHlDGwooUEpG6uvz4f9N_ZRIBtgW0DHvPBortetV78L4F9dJDHLMXm6zlzl7OWYv11mJXymfzP-nqbaalFm_NPHZ0G-KHgBYqL_P |
CitedBy_id | crossref_primary_10_1371_journal_pone_0187600 crossref_primary_10_1371_journal_pone_0216410 crossref_primary_10_1002_brb3_1032 crossref_primary_10_1016_j_msard_2022_103761 crossref_primary_10_3389_fnins_2021_692599 crossref_primary_10_1016_S1474_4422_17_30278_8 crossref_primary_10_3390_brainsci14010036 crossref_primary_10_1097_WNO_0000000000001280 crossref_primary_10_1136_jnnp_2024_334801 crossref_primary_10_1016_j_jns_2018_01_020 crossref_primary_10_1177_17562864211003478 crossref_primary_10_1016_S1474_4422_21_00218_0 crossref_primary_10_1016_j_msard_2018_03_007 crossref_primary_10_1007_s40263_018_0521_9 crossref_primary_10_1016_j_jns_2021_117552 crossref_primary_10_4103_tjo_tjo_76_20 crossref_primary_10_1212_NXI_0000000000200269 crossref_primary_10_1136_bmjno_2023_000560 crossref_primary_10_1007_s11940_017_0452_7 crossref_primary_10_3389_fneur_2020_628542 crossref_primary_10_1016_j_jns_2023_120552 crossref_primary_10_1212_NXI_0000000000001051 crossref_primary_10_1002_acn3_51473 crossref_primary_10_1016_j_compbiomed_2020_104165 crossref_primary_10_1111_cns_70225 crossref_primary_10_1177_1352458518817987 crossref_primary_10_1177_1352458516677590 crossref_primary_10_1097_WNO_0000000000000802 crossref_primary_10_1002_ana_26440 crossref_primary_10_1007_s00115_022_01302_5 crossref_primary_10_1111_ene_16529 crossref_primary_10_1167_tvst_8_3_34 crossref_primary_10_1371_journal_pone_0289495 crossref_primary_10_1097_WCO_0000000000000604 crossref_primary_10_1159_000510116 crossref_primary_10_1186_s12886_021_02158_0 crossref_primary_10_1016_j_msard_2025_106259 crossref_primary_10_1212_WNL_0000000000200977 crossref_primary_10_1007_s00415_018_8988_3 crossref_primary_10_1212_NXI_0000000000000671 crossref_primary_10_1007_s10633_021_09855_7 crossref_primary_10_1080_01616412_2020_1761174 crossref_primary_10_1007_s11940_018_0493_6 crossref_primary_10_2217_nmt_2018_0011 crossref_primary_10_1097_IAE_0000000000002043 crossref_primary_10_3389_fneur_2021_615790 crossref_primary_10_1038_s41598_024_53830_6 crossref_primary_10_1177_17562864221118731 crossref_primary_10_1016_j_msard_2018_02_010 crossref_primary_10_1097_WNO_0000000000002244 crossref_primary_10_1038_s41467_024_49309_7 crossref_primary_10_1016_j_jns_2023_120847 crossref_primary_10_1007_s00415_021_10469_x crossref_primary_10_1038_s41598_022_06821_4 crossref_primary_10_1016_j_msard_2022_104255 crossref_primary_10_1016_j_compbiomed_2021_104416 crossref_primary_10_1080_00207454_2019_1576660 crossref_primary_10_1212_NXI_0000000000000572 crossref_primary_10_1038_s41598_021_86061_0 crossref_primary_10_1111_epi_18139 crossref_primary_10_1371_journal_pone_0288581 crossref_primary_10_1007_s00415_016_8271_4 crossref_primary_10_3390_jcm14061998 crossref_primary_10_1177_1352458517694090 crossref_primary_10_1186_s41983_020_00204_0 crossref_primary_10_1007_s10072_024_07664_9 crossref_primary_10_1515_biol_2022_0866 crossref_primary_10_1097_WCO_0000000000000418 crossref_primary_10_1007_s00347_022_01728_x crossref_primary_10_1212_NXI_0000000000000449 crossref_primary_10_1016_j_msard_2019_101414 crossref_primary_10_1002_brb3_1467 crossref_primary_10_1016_j_compbiomed_2021_104822 crossref_primary_10_1080_23808993_2017_1393315 crossref_primary_10_3389_fneur_2019_01117 crossref_primary_10_1038_s41598_022_24312_4 crossref_primary_10_1136_jnnp_2023_331183 crossref_primary_10_1186_s12974_019_1521_5 crossref_primary_10_1007_s00415_022_11449_5 crossref_primary_10_1212_WNL_0000000000201223 crossref_primary_10_1212_WNL_0000000000006189 crossref_primary_10_1155_2021_5573839 crossref_primary_10_1080_14737175_2019_1559051 crossref_primary_10_3389_fneur_2017_00675 crossref_primary_10_1093_braincomms_fcac065 crossref_primary_10_1073_pnas_2115973119 crossref_primary_10_1177_2040622319882205 crossref_primary_10_1136_jnnp_2021_327468 crossref_primary_10_1212_WNL_0000000000011928 crossref_primary_10_1212_NXI_0000000000001155 crossref_primary_10_3390_ijms241612872 crossref_primary_10_1136_jnnp_2023_332332 crossref_primary_10_1097_WNO_0000000000000662 crossref_primary_10_24875_RMO_M18000062 crossref_primary_10_1007_s10072_020_04431_4 crossref_primary_10_1093_brain_awz188 crossref_primary_10_1002_ana_25738 crossref_primary_10_1177_11206721221112803 crossref_primary_10_1177_1352458517739136 crossref_primary_10_1001_jamaneurol_2018_1011 crossref_primary_10_1177_1352458519872751 crossref_primary_10_3390_jcm8112022 crossref_primary_10_1186_s12974_019_1583_4 |
Cites_doi | 10.1136/jnnp-2013-306902 10.1016/S1474-4422(12)70213-2 10.1212/01.wnl.0000260612.51849.ed 10.1007/978-1-4471-6380-0_14 10.1146/annurev.neuro.30.051606.094313 10.1002/ana.21436 10.1016/j.jns.2009.02.354 10.1093/brain/awh126 10.1177/1352458509106510 10.1111/ene.12532 10.1177/1352458514523498 10.1007/s00415-010-5467-x 10.1111/ene.12070 10.1167/iovs.13-12073 10.1001/jamaneurol.2013.573 10.1177/1352458514542862 10.1093/brain/awq080 10.1167/iovs.13-12912 10.1177/1352458513489757 10.1038/nrneurol.2014.108 10.1177/1352458514538110 10.1212/WNL.46.4.907 10.1002/ana.24351 10.1177/1352458512439237 10.1212/01.WNL.0000055926.69643.03 10.1002/ana.24030 10.1002/ana.20575 10.1371/journal.pone.0030922 10.1212/WNL.33.11.1444 10.1093/brain/aws098 10.1093/brain/awr264 10.1016/S1474-4422(10)70168-X 10.1097/WNO.0b013e318238937f 10.1371/journal.pone.0036847 10.1002/ana.21423 10.1002/ana.24487 10.1002/ana.22005 10.1155/2013/134858 |
ContentType | Journal Article |
Copyright | The Author(s) 2016 Springer-Verlag Berlin Heidelberg 2016 |
Copyright_xml | – notice: The Author(s) 2016 – notice: Springer-Verlag Berlin Heidelberg 2016 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1007/s00415-016-8127-y |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Proquest Health and Medical Complete ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection Neurosciences Abstracts ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE - Academic MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-1459 |
EndPage | 1331 |
ExternalDocumentID | PMC4929170 4105112221 27142714 10_1007_s00415_016_8127_y |
Genre | Journal Article |
GeographicLocations | Netherlands San Francisco California California United Kingdom--UK United States--US |
GeographicLocations_xml | – name: San Francisco California – name: California – name: Netherlands – name: United Kingdom--UK – name: United States--US |
GrantInformation_xml | – fundername: Stichting MS Research grantid: personal travel grant funderid: http://dx.doi.org/10.13039/501100003000 – fundername: ; grantid: personal travel grant |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3SX 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFFNX AFJLC AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C6C CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 X7M YLTOR Z45 Z7U Z81 Z82 Z83 Z87 Z8O Z8U Z8V Z8W Z91 Z92 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7TK 7XB 8FK ABRTQ K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c503t-bb1a8a9f937f2c53f7fee44fc84888c496d78f763d28b05814af890e04908cd83 |
IEDL.DBID | U2A |
ISSN | 0340-5354 1432-1459 |
IngestDate | Thu Aug 21 13:59:19 EDT 2025 Thu Aug 07 14:59:33 EDT 2025 Sun Aug 24 04:08:51 EDT 2025 Fri Jul 25 02:03:04 EDT 2025 Wed Feb 19 02:03:56 EST 2025 Tue Jul 01 01:31:21 EDT 2025 Thu Apr 24 22:51:13 EDT 2025 Fri Feb 21 02:41:42 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Retina Multiple sclerosis Optical coherence tomography RNFL Neurodegeneration |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c503t-bb1a8a9f937f2c53f7fee44fc84888c496d78f763d28b05814af890e04908cd83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://link.springer.com/10.1007/s00415-016-8127-y |
PMID | 27142714 |
PQID | 1800606647 |
PQPubID | 47196 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4929170 proquest_miscellaneous_1808727466 proquest_miscellaneous_1801426957 proquest_journals_1800606647 pubmed_primary_27142714 crossref_citationtrail_10_1007_s00415_016_8127_y crossref_primary_10_1007_s00415_016_8127_y springer_journals_10_1007_s00415_016_8127_y |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-07-01 |
PublicationDateYYYYMMDD | 2016-07-01 |
PublicationDate_xml | – month: 07 year: 2016 text: 2016-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
PublicationSubtitle | Official Journal of the European Neurological Society |
PublicationTitle | Journal of neurology |
PublicationTitleAbbrev | J Neurol |
PublicationTitleAlternate | J Neurol |
PublicationYear | 2016 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | Dalton, Chard, Davies, Miszkiel, Altmann, Fernando (CR3) 2004; 127 Schippling, Balk, Costello, Albrecht, Balcer, Calabresi (CR29) 2014; 21 Martinez-Lapiscina, Sanchez-Dalmau, Fraga-Pumar, Ortiz-Perez, Tercero-Uribe, Torres-Torres (CR9) 2014; 20 Trapp, Nave (CR1) 2008; 31 Green, McQuaid, Hauser, Allen, Lyness (CR20) 2010; 133 Kurtzke (CR26) 1983; 33 Oberwahrenbrock, Ringelstein, Jentschke, Deuschle, Klumbies, Bellmann-Strobl (CR23) 2013; 19 Gelfand, Nolan, Schwartz, Graves, Green (CR34) 2012; 135 Gabilondo, Martinez-Lapiscina, Fraga-Pumar, Ortiz-Perez, Torres-Torres, Andorra (CR38) 2015; 77 Huhn, Lammer, Oberwahrenbrock, Lammer, Waschbisch, Gosar (CR24) 2014; 22 Burggraaff, Trieu, de Vries-Knoppert, Balk, Petzold (CR30) 2014; 55 Costello (CR8) 2013; 2013 Albrecht, Ringelstein, Muller, Keser, Dietlein, Lappas (CR11) 2012; 18 Trip, Schlottmann, Jones, Altmann, Garway-Heath, Thompson (CR17) 2005; 58 Lublin, Reingold (CR25) 1996; 46 Young, Brandt, Petzold, Reitz, Lintze, Paul (CR22) 2013; 20 Costello, Hodge, Pan, Freedman, DeMeulemeester (CR31) 2009; 281 Balk, Twisk, Steenwijk, Daams, Tewarie, Killestein (CR10) 2014; 85 Petzold, Wattjes, Costello, Flores-Rivera, Fraser, Fujihara (CR27) 2014; 10 Narayanan, Cheng, Bonem, Saenz, Tang, Frishman (CR32) 2014; 20 Fisher, Lee, Nakamura, Rudick (CR6) 2008; 64 Saidha, Sotirchos, Ibrahim, Crainiceanu, Gelfand, Sepah (CR35) 2012; 11 Sakai, Feller, Galetta, Galetta, Balcer (CR15) 2011; 31 Tatrai, Simo, Iljicsov, Nemeth, Debuc, Somfai (CR14) 2012; 7 Syc, Saidha, Newsome, Ratchford, Levy, Ford (CR37) 2012; 135 Talman, Bisker, Sackel, Long, Galetta, Ratchford (CR18) 2010; 67 Fisniku, Chard, Jackson, Anderson, Altmann, Miszkiel (CR7) 2008; 64 Gabilondo, Martinez-Lapiscina, Martinez-Heras, Fraga-Pumar, Llufriu, Ortiz (CR12) 2014; 75 Saidha, Al-Louzi, Ratchford, Bhargava, Oh, Newsome (CR33) 2015 Sepulcre, Murie-Fernandez, Salinas-Alaman, Garcia-Layana, Bejarano, Villoslada (CR16) 2007; 68 Henderson, Trip, Schlottmann, Altmann, Garway-Heath, Plant (CR19) 2010; 257 Saidha, Sotirchos, Oh, Syc, Seigo, Shiee (CR13) 2013; 70 Gelfand, Goodin, Boscardin, Nolan, Cuneo, Green (CR21) 2012; 7 De, Matthews, Filippi, Agosta, De, Bartolozzi (CR4) 2003; 60 Petzold, Galimberti, Scaroini (CR2) 2014 Calabrese, Gallo (CR5) 2009; 15 Balk, Petzold (CR28) 2013; 54 Petzold, de Boer, Schippling, Vermersch, Kardon, Green (CR36) 2010; 9 JM Gelfand (8127_CR21) 2012; 7 S Saidha (8127_CR33) 2015 CM Dalton (8127_CR3) 2004; 127 LS Talman (8127_CR18) 2010; 67 AJ Green (8127_CR20) 2010; 133 E Fisher (8127_CR6) 2008; 64 K Huhn (8127_CR24) 2014; 22 F Costello (8127_CR31) 2009; 281 SN De (8127_CR4) 2003; 60 I Gabilondo (8127_CR12) 2014; 75 J Sepulcre (8127_CR16) 2007; 68 JF Kurtzke (8127_CR26) 1983; 33 S Saidha (8127_CR35) 2012; 11 E Tatrai (8127_CR14) 2012; 7 BD Trapp (8127_CR1) 2008; 31 A Petzold (8127_CR27) 2014; 10 A Petzold (8127_CR2) 2014 F Costello (8127_CR8) 2013; 2013 P Albrecht (8127_CR11) 2012; 18 LJ Balk (8127_CR28) 2013; 54 LJ Balk (8127_CR10) 2014; 85 A Petzold (8127_CR36) 2010; 9 RE Sakai (8127_CR15) 2011; 31 SB Syc (8127_CR37) 2012; 135 APD Henderson (8127_CR19) 2010; 257 S Schippling (8127_CR29) 2014; 21 E Martinez-Lapiscina (8127_CR9) 2014; 20 I Gabilondo (8127_CR38) 2015; 77 S Saidha (8127_CR13) 2013; 70 LK Fisniku (8127_CR7) 2008; 64 M Calabrese (8127_CR5) 2009; 15 SA Trip (8127_CR17) 2005; 58 T Oberwahrenbrock (8127_CR23) 2013; 19 MC Burggraaff (8127_CR30) 2014; 55 D Narayanan (8127_CR32) 2014; 20 KL Young (8127_CR22) 2013; 20 FD Lublin (8127_CR25) 1996; 46 JM Gelfand (8127_CR34) 2012; 135 23041237 - Lancet Neurol. 2012 Nov;11(11):963-72 23633680 - Invest Ophthalmol Vis Sci. 2013 Apr 30;54(4):3045 24639478 - Mult Scler. 2014 Sep;20(10):1331-41 24948688 - Mult Scler. 2015 Feb;21(2):163-70 18570297 - Ann Neurol. 2008 Sep;64(3):247-54 19303605 - J Neurol Sci. 2009 Jun 15;281(1-2):74-9 25559267 - Ann Neurol. 2015 Mar;77(3):517-28 24474822 - J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):782-9 18558855 - Annu Rev Neurosci. 2008;31:247-69 25002105 - Nat Rev Neurol. 2014 Aug;10(8):447-58 20143110 - J Neurol. 2010 Jul;257(7):1083-91 22666330 - PLoS One. 2012;7(5):e36847 12682324 - Neurology. 2003 Apr 8;60(7):1157-62 16075460 - Ann Neurol. 2005 Sep;58(3):383-91 23702433 - Mult Scler. 2013 Dec;19(14):1887-95 25104178 - Eur J Neurol. 2015 Jan;22(1):86-92 25013155 - Mult Scler. 2014 Nov;20(13):1678-85 14998914 - Brain. 2004 May;127(Pt 5):1101-7 23318513 - JAMA Neurol. 2013 Jan;70(1):34-43 20723847 - Lancet Neurol. 2010 Sep;9(9):921-32 8780061 - Neurology. 1996 Apr;46(4):907-11 22292076 - PLoS One. 2012;7(1):e30922 22539259 - Brain. 2012 Jun;135(Pt 6):1786-93 22089500 - J Neuroophthalmol. 2011 Dec;31(4):362-73 22006982 - Brain. 2012 Feb;135(Pt 2):521-33 24398089 - Invest Ophthalmol Vis Sci. 2014 Feb 18;55(2):952-61 22389411 - Mult Scler. 2012 Oct;18(10):1422-9 6685237 - Neurology. 1983 Nov;33(11):1444-52 17470751 - Neurology. 2007 May 1;68(18):1488-94 24288622 - ISRN Neurol. 2013 Nov 06;2013:134858 19667021 - Mult Scler. 2009 Aug;15(8):933-41 20410146 - Brain. 2010 Jun;133(Pt 6):1591-601 26190464 - Ann Neurol. 2015 Nov;78(5):801-13 23369013 - Eur J Neurol. 2013 May;20(5):803-11 18661561 - Ann Neurol. 2008 Sep;64(3):255-65 24114885 - Ann Neurol. 2014 Jan;75(1):98-107 20517936 - Ann Neurol. 2010 Jun;67(6):749-60 |
References_xml | – volume: 85 start-page: 782 issue: 7 year: 2014 end-page: 789 ident: CR10 article-title: A dam for retrograde axonal degeneration in multiple sclerosis? publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2013-306902 – volume: 11 start-page: 963 issue: 11 year: 2012 end-page: 972 ident: CR35 article-title: Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(12)70213-2 – volume: 68 start-page: 1488 issue: 18 year: 2007 end-page: 1494 ident: CR16 article-title: Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS publication-title: Neurology doi: 10.1212/01.wnl.0000260612.51849.ed – start-page: 227 year: 2014 end-page: 245 ident: CR2 article-title: Neurodegeneration and multiple sclerosis publication-title: Neurodegenerative diseases doi: 10.1007/978-1-4471-6380-0_14 – volume: 31 start-page: 247 year: 2008 end-page: 269 ident: CR1 article-title: Multiple sclerosis: an immune or neurodegenerative disorder? publication-title: Annu Rev Neurosci doi: 10.1146/annurev.neuro.30.051606.094313 – volume: 64 start-page: 255 issue: 3 year: 2008 end-page: 265 ident: CR6 article-title: Gray matter atrophy in multiple sclerosis: a longitudinal study publication-title: Ann Neurol doi: 10.1002/ana.21436 – volume: 281 start-page: 74 issue: 1–2 year: 2009 end-page: 79 ident: CR31 article-title: Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes publication-title: J Neurol Sci doi: 10.1016/j.jns.2009.02.354 – volume: 127 start-page: 1101 year: 2004 end-page: 1107 ident: CR3 article-title: Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes publication-title: Brain doi: 10.1093/brain/awh126 – volume: 15 start-page: 933 issue: 8 year: 2009 end-page: 941 ident: CR5 article-title: Magnetic resonance evidence of cortical onset of multiple sclerosis publication-title: Mult Scler doi: 10.1177/1352458509106510 – volume: 22 start-page: 86 issue: 1 year: 2014 end-page: 92 ident: CR24 article-title: Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage publication-title: Eur J Neurol doi: 10.1111/ene.12532 – year: 2015 ident: CR33 article-title: Optical coherence tomography reflects brain atrophy in MS: a four year study publication-title: Ann Neurol – volume: 20 start-page: 1331 issue: 10 year: 2014 end-page: 1341 ident: CR32 article-title: Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis publication-title: Mult Scler doi: 10.1177/1352458514523498 – volume: 257 start-page: 1083 issue: 7 year: 2010 end-page: 1091 ident: CR19 article-title: A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis publication-title: J Neurol doi: 10.1007/s00415-010-5467-x – volume: 20 start-page: 803 issue: 5 year: 2013 end-page: 811 ident: CR22 article-title: Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis publication-title: Eur J Neurol doi: 10.1111/ene.12070 – volume: 54 start-page: 3045 issue: 4 year: 2013 ident: CR28 article-title: Influence of the eye-tracking-based follow-up function in retinal nerve fiber layer thickness using fourier-domain optical coherence tomography publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.13-12073 – volume: 70 start-page: 34 issue: 1 year: 2013 end-page: 43 ident: CR13 article-title: Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2013.573 – volume: 20 start-page: 1678 issue: 13 year: 2014 end-page: 1685 ident: CR9 article-title: The visual pathway as a model to understand brain damage in multiple sclerosis publication-title: Mult Scler doi: 10.1177/1352458514542862 – volume: 133 start-page: 1591 issue: Pt 6 year: 2010 end-page: 1601 ident: CR20 article-title: Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration publication-title: Brain doi: 10.1093/brain/awq080 – volume: 55 start-page: 952 issue: 2 year: 2014 end-page: 961 ident: CR30 article-title: The clinical spectrum of microcystic macular edema publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.13-12912 – volume: 19 start-page: 1887 issue: 14 year: 2013 end-page: 1895 ident: CR23 article-title: Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome publication-title: Mult Scler doi: 10.1177/1352458513489757 – volume: 10 start-page: 447 issue: 8 year: 2014 end-page: 458 ident: CR27 article-title: The investigation of acute optic neuritis: a review and proposed protocol publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2014.108 – volume: 2013 start-page: 134858 year: 2013 ident: CR8 article-title: The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis publication-title: ISRN Neurol – volume: 21 start-page: 163 issue: 2 year: 2014 end-page: 170 ident: CR29 article-title: Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria publication-title: Mult Scler doi: 10.1177/1352458514538110 – volume: 46 start-page: 907 issue: 4 year: 1996 end-page: 911 ident: CR25 article-title: Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis publication-title: Neurology doi: 10.1212/WNL.46.4.907 – volume: 67 start-page: 749 issue: 6 year: 2010 end-page: 760 ident: CR18 article-title: Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis publication-title: Ann Neurol – volume: 77 start-page: 517 issue: 3 year: 2015 end-page: 528 ident: CR38 article-title: Dynamics of retinal injury after acute optic neuritis publication-title: Ann Neurol doi: 10.1002/ana.24351 – volume: 18 start-page: 1422 issue: 10 year: 2012 end-page: 1429 ident: CR11 article-title: Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography publication-title: Mult Scler doi: 10.1177/1352458512439237 – volume: 60 start-page: 1157 issue: 7 year: 2003 end-page: 1162 ident: CR4 article-title: Evidence of early cortical atrophy in MS: relevance to white matter changes and disability publication-title: Neurology 8 doi: 10.1212/01.WNL.0000055926.69643.03 – volume: 75 start-page: 98 issue: 1 year: 2014 end-page: 107 ident: CR12 article-title: Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis publication-title: Ann Neurol doi: 10.1002/ana.24030 – volume: 58 start-page: 383 issue: 3 year: 2005 end-page: 391 ident: CR17 article-title: Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis publication-title: Ann Neurol doi: 10.1002/ana.20575 – volume: 7 start-page: e30922 issue: 1 year: 2012 ident: CR14 article-title: In vivo evaluation of retinal neurodegeneration in patients with multiple sclerosis publication-title: PLoS One doi: 10.1371/journal.pone.0030922 – volume: 33 start-page: 1444 issue: 11 year: 1983 end-page: 1452 ident: CR26 article-title: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) publication-title: Neurology doi: 10.1212/WNL.33.11.1444 – volume: 135 start-page: 1786 issue: Pt 6 year: 2012 end-page: 1793 ident: CR34 article-title: Microcystic macular oedema in multiple sclerosis is associated with disease severity publication-title: Brain doi: 10.1093/brain/aws098 – volume: 135 start-page: 521 issue: Pt 2 year: 2012 end-page: 533 ident: CR37 article-title: Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis publication-title: Brain doi: 10.1093/brain/awr264 – volume: 9 start-page: 921 issue: 9 year: 2010 end-page: 932 ident: CR36 article-title: Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70168-X – volume: 31 start-page: 362 issue: 4 year: 2011 end-page: 373 ident: CR15 article-title: Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection publication-title: J Neuroophthalmol doi: 10.1097/WNO.0b013e318238937f – volume: 7 start-page: e36847 issue: 5 year: 2012 ident: CR21 article-title: Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes publication-title: PLoS One doi: 10.1371/journal.pone.0036847 – volume: 64 start-page: 247 issue: 3 year: 2008 end-page: 254 ident: CR7 article-title: Gray matter atrophy is related to long-term disability in multiple sclerosis publication-title: Ann Neurol doi: 10.1002/ana.21423 – volume: 54 start-page: 3045 issue: 4 year: 2013 ident: 8127_CR28 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.13-12073 – volume: 64 start-page: 247 issue: 3 year: 2008 ident: 8127_CR7 publication-title: Ann Neurol doi: 10.1002/ana.21423 – volume: 20 start-page: 1331 issue: 10 year: 2014 ident: 8127_CR32 publication-title: Mult Scler doi: 10.1177/1352458514523498 – volume: 127 start-page: 1101 year: 2004 ident: 8127_CR3 publication-title: Brain doi: 10.1093/brain/awh126 – volume: 20 start-page: 1678 issue: 13 year: 2014 ident: 8127_CR9 publication-title: Mult Scler doi: 10.1177/1352458514542862 – volume: 33 start-page: 1444 issue: 11 year: 1983 ident: 8127_CR26 publication-title: Neurology doi: 10.1212/WNL.33.11.1444 – year: 2015 ident: 8127_CR33 publication-title: Ann Neurol doi: 10.1002/ana.24487 – volume: 15 start-page: 933 issue: 8 year: 2009 ident: 8127_CR5 publication-title: Mult Scler doi: 10.1177/1352458509106510 – volume: 31 start-page: 247 year: 2008 ident: 8127_CR1 publication-title: Annu Rev Neurosci doi: 10.1146/annurev.neuro.30.051606.094313 – start-page: 227 volume-title: Neurodegenerative diseases year: 2014 ident: 8127_CR2 doi: 10.1007/978-1-4471-6380-0_14 – volume: 21 start-page: 163 issue: 2 year: 2014 ident: 8127_CR29 publication-title: Mult Scler doi: 10.1177/1352458514538110 – volume: 75 start-page: 98 issue: 1 year: 2014 ident: 8127_CR12 publication-title: Ann Neurol doi: 10.1002/ana.24030 – volume: 20 start-page: 803 issue: 5 year: 2013 ident: 8127_CR22 publication-title: Eur J Neurol doi: 10.1111/ene.12070 – volume: 7 start-page: e30922 issue: 1 year: 2012 ident: 8127_CR14 publication-title: PLoS One doi: 10.1371/journal.pone.0030922 – volume: 67 start-page: 749 issue: 6 year: 2010 ident: 8127_CR18 publication-title: Ann Neurol doi: 10.1002/ana.22005 – volume: 70 start-page: 34 issue: 1 year: 2013 ident: 8127_CR13 publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2013.573 – volume: 7 start-page: e36847 issue: 5 year: 2012 ident: 8127_CR21 publication-title: PLoS One doi: 10.1371/journal.pone.0036847 – volume: 281 start-page: 74 issue: 1–2 year: 2009 ident: 8127_CR31 publication-title: J Neurol Sci doi: 10.1016/j.jns.2009.02.354 – volume: 18 start-page: 1422 issue: 10 year: 2012 ident: 8127_CR11 publication-title: Mult Scler doi: 10.1177/1352458512439237 – volume: 60 start-page: 1157 issue: 7 year: 2003 ident: 8127_CR4 publication-title: Neurology 8 doi: 10.1212/01.WNL.0000055926.69643.03 – volume: 22 start-page: 86 issue: 1 year: 2014 ident: 8127_CR24 publication-title: Eur J Neurol doi: 10.1111/ene.12532 – volume: 46 start-page: 907 issue: 4 year: 1996 ident: 8127_CR25 publication-title: Neurology doi: 10.1212/WNL.46.4.907 – volume: 85 start-page: 782 issue: 7 year: 2014 ident: 8127_CR10 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2013-306902 – volume: 55 start-page: 952 issue: 2 year: 2014 ident: 8127_CR30 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.13-12912 – volume: 2013 start-page: 134858 year: 2013 ident: 8127_CR8 publication-title: ISRN Neurol doi: 10.1155/2013/134858 – volume: 135 start-page: 1786 issue: Pt 6 year: 2012 ident: 8127_CR34 publication-title: Brain doi: 10.1093/brain/aws098 – volume: 10 start-page: 447 issue: 8 year: 2014 ident: 8127_CR27 publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2014.108 – volume: 133 start-page: 1591 issue: Pt 6 year: 2010 ident: 8127_CR20 publication-title: Brain doi: 10.1093/brain/awq080 – volume: 58 start-page: 383 issue: 3 year: 2005 ident: 8127_CR17 publication-title: Ann Neurol doi: 10.1002/ana.20575 – volume: 257 start-page: 1083 issue: 7 year: 2010 ident: 8127_CR19 publication-title: J Neurol doi: 10.1007/s00415-010-5467-x – volume: 77 start-page: 517 issue: 3 year: 2015 ident: 8127_CR38 publication-title: Ann Neurol doi: 10.1002/ana.24351 – volume: 9 start-page: 921 issue: 9 year: 2010 ident: 8127_CR36 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70168-X – volume: 19 start-page: 1887 issue: 14 year: 2013 ident: 8127_CR23 publication-title: Mult Scler doi: 10.1177/1352458513489757 – volume: 31 start-page: 362 issue: 4 year: 2011 ident: 8127_CR15 publication-title: J Neuroophthalmol doi: 10.1097/WNO.0b013e318238937f – volume: 11 start-page: 963 issue: 11 year: 2012 ident: 8127_CR35 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(12)70213-2 – volume: 64 start-page: 255 issue: 3 year: 2008 ident: 8127_CR6 publication-title: Ann Neurol doi: 10.1002/ana.21436 – volume: 135 start-page: 521 issue: Pt 2 year: 2012 ident: 8127_CR37 publication-title: Brain doi: 10.1093/brain/awr264 – volume: 68 start-page: 1488 issue: 18 year: 2007 ident: 8127_CR16 publication-title: Neurology doi: 10.1212/01.wnl.0000260612.51849.ed – reference: 24114885 - Ann Neurol. 2014 Jan;75(1):98-107 – reference: 8780061 - Neurology. 1996 Apr;46(4):907-11 – reference: 22539259 - Brain. 2012 Jun;135(Pt 6):1786-93 – reference: 16075460 - Ann Neurol. 2005 Sep;58(3):383-91 – reference: 20517936 - Ann Neurol. 2010 Jun;67(6):749-60 – reference: 23041237 - Lancet Neurol. 2012 Nov;11(11):963-72 – reference: 17470751 - Neurology. 2007 May 1;68(18):1488-94 – reference: 20410146 - Brain. 2010 Jun;133(Pt 6):1591-601 – reference: 26190464 - Ann Neurol. 2015 Nov;78(5):801-13 – reference: 24288622 - ISRN Neurol. 2013 Nov 06;2013:134858 – reference: 25559267 - Ann Neurol. 2015 Mar;77(3):517-28 – reference: 25104178 - Eur J Neurol. 2015 Jan;22(1):86-92 – reference: 23369013 - Eur J Neurol. 2013 May;20(5):803-11 – reference: 6685237 - Neurology. 1983 Nov;33(11):1444-52 – reference: 22389411 - Mult Scler. 2012 Oct;18(10):1422-9 – reference: 18661561 - Ann Neurol. 2008 Sep;64(3):255-65 – reference: 19667021 - Mult Scler. 2009 Aug;15(8):933-41 – reference: 22089500 - J Neuroophthalmol. 2011 Dec;31(4):362-73 – reference: 25013155 - Mult Scler. 2014 Nov;20(13):1678-85 – reference: 20723847 - Lancet Neurol. 2010 Sep;9(9):921-32 – reference: 19303605 - J Neurol Sci. 2009 Jun 15;281(1-2):74-9 – reference: 18570297 - Ann Neurol. 2008 Sep;64(3):247-54 – reference: 22006982 - Brain. 2012 Feb;135(Pt 2):521-33 – reference: 24474822 - J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):782-9 – reference: 22292076 - PLoS One. 2012;7(1):e30922 – reference: 20143110 - J Neurol. 2010 Jul;257(7):1083-91 – reference: 24948688 - Mult Scler. 2015 Feb;21(2):163-70 – reference: 18558855 - Annu Rev Neurosci. 2008;31:247-69 – reference: 22666330 - PLoS One. 2012;7(5):e36847 – reference: 24398089 - Invest Ophthalmol Vis Sci. 2014 Feb 18;55(2):952-61 – reference: 14998914 - Brain. 2004 May;127(Pt 5):1101-7 – reference: 25002105 - Nat Rev Neurol. 2014 Aug;10(8):447-58 – reference: 12682324 - Neurology. 2003 Apr 8;60(7):1157-62 – reference: 23702433 - Mult Scler. 2013 Dec;19(14):1887-95 – reference: 24639478 - Mult Scler. 2014 Sep;20(10):1331-41 – reference: 23633680 - Invest Ophthalmol Vis Sci. 2013 Apr 30;54(4):3045 – reference: 23318513 - JAMA Neurol. 2013 Jan;70(1):34-43 |
SSID | ssj0008459 |
Score | 2.503739 |
Snippet | The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1323 |
SubjectTerms | Adult Atrophy Atrophy - diagnostic imaging Atrophy - etiology Axons - pathology Female Humans Longitudinal Studies Male Medicine Medicine & Public Health Middle Aged Multiple sclerosis Multiple Sclerosis - complications Nervous system Neurology Neuroradiology Neurosciences Optics Original Communication Patients Retina - diagnostic imaging Retina - pathology Retinal Neurons - pathology Time Factors Tomography Tomography, Optical Coherence Visual Pathways - diagnostic imaging |
SummonAdditionalLinks | – databaseName: Proquest Health and Medical Complete dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dSxwxEB-qBfGl9MPqWltS6FMlNNmdbLJ9KUUqIlx98IR7W3aTjR7IntY70P--mdzu1qt4DwtZMoEkM8lMMpPfAHxpMqyUMuGkqtFz9FrxwhvJHQbtZL2zGJGYRr_zkws8nahJd-F214VV9nti3KjdzNId-TdpCDokz1H_uLnllDWKvKtdCo0NeEnQZRTSpSfDgUsYjMnSRIaCq0xh79UUSxBRSWFrOQ8qTvOHVb30xNh8GjP5n-M06qPj1_CqMyTZzyXn38CLpn0LW6POVf4OTseUr-uSzTyjh4pEG7ErqVC1jlX3sXgdOsOmLRudf2dV-KP0RQsXyc-Oxiyiz-7AxfGv8dEJ7xIncKtENud1LStTFT6YHj61KvPaNw2ityYsV2OxyJ02PuwsLjW1UEZi5U0hmugFtM5k72GznbXNHjCtdV1ol-beOCy0rNNCohPSojC1sUUCop-20nao4pTc4roc8JDjTJcUSUYzXT4k8HVocrOE1FhHfNDzouxW1135TxYS-DxUh3VBzo6qbWaLSCPpma5aT2OC_YZ5nsDukr1Dj1IdmocvAb3C-IGAcLlXa9rpVcTnxmBySi0SOOxF5FHXnxvo_vqBfoDtlIQ1BgofwOb8z6L5GMyhef0pyvxfEcQExQ priority: 102 providerName: ProQuest |
Title | Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study |
URI | https://link.springer.com/article/10.1007/s00415-016-8127-y https://www.ncbi.nlm.nih.gov/pubmed/27142714 https://www.proquest.com/docview/1800606647 https://www.proquest.com/docview/1801426957 https://www.proquest.com/docview/1808727466 https://pubmed.ncbi.nlm.nih.gov/PMC4929170 |
Volume | 263 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_WFsZeyr7rtQsq7GlDINmnD_ctC-lKS7qxJZA9GVuy2kJxyprA-t9PUmyzrFthD8aydTKyTtKduLvfAbyrMyyF0P6kqtBRdErQ3GlOLXrpZJw1GJGYJufyZIanczFv47hvO2_3ziQZd-o-2C1AQwVHM0m9UFL0bgt2RDi6-0k8S4f99qsxZkhjGTIqMoGdKfNvn9gURvc0zPuOkn9YS6MQOn4Ku632SIZrdj-DR3XzHB5PWvv4CzidhiRdF2ThSIhODLQRsDIUysaS8mcsXvvOkKuGTL4dkdI_hZxFKxvJP4-mJELOvoTZ8Xg6OqFttgRqBMuWtKp4qcvceX3DpUZkTrm6RnRG-zWqDebSKu38dmJTXTGhOZZO56yOpj9jdfYKtptFU-8BUUpVubKpdNpirniV5hwt4waZrrTJE2DdsBWmhRIPGS2uix4EOY50EdzHwkgXdwm875vcrHE0HiI-6HhRtEvqtuA6YMdIiSqBw77aL4Zg4SiberGKNDzE5oqHabRX2lDKBF6v2dv3KFW-ub8SUBuM7wkCGPdmTXN1GUG50euZXLEEPnRT5Leu_-tH3_wX9T48ScPcjc7CB7C9_LGq33qVaFkNYEvN1QB2hp--n439_eP4_MtX_3YkR4O4PH4BZkwGwg |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYwEF5BVOxnHDhJCUFptH7sg2Eq9hcSOoVKVLXRXsH-K34jtPGCp2FsPkRx5HPkx4xlnxt8APK0SLIRQ7qQq0VK0UtDMKk4NOu2krdEYkJhG43R4iHtH4mgNfnV3YXxYZbcnho3aTLX_R77JlYcOSVOUr0-_UZ81yntXuxQaDVvsV4sf7sh29mr3nVvfZ3G8sz3ZGtI2qwDVgiUzWpa8UEVmnV62sRaJlbaqEK1WjpeVxiw1UlkndiZWJROKY2FVxqrgItNGJe67l2AdE3eUGcD62-3xh4_93q8wpGdjCTIqEoGdH5U1sKXcB8ql1ClVSRfLmvCceXs-SvMfV23QgDvX4VprupI3Da_dgLWqvgmXR61z_hbsTXyGsC9kaom_GulpA1qmLxS1IcXPUDxxnSHHNRl9ekkK9-YTJs1NIH-_NSEB7_Y2HF7IpN6BQT2tq3tApJRlJk2cWmUwk7yMM46GcY1MlUpnEbBu2nLd4pj7dBoneY_AHGY697FrfqbzRQTP-yanDYjHKuKNbi3yVp7P8j_cF8GTvtpJonevFHU1nQca7i8Gi9U0ylmMmKYR3G2Wt-9RLF1z90Qglxa-J_BI4Ms19fHXgAiOzsjlkkXwomORv7r-v4HeXz3Qx3BlOBkd5Ae74_0HcDX2jBvClDdgMPs-rx46Y2xWPmolgMDnixa634PUQsg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxQxEB9qheJL8dutVSPoixKa7E42WUFEWo9-eFXwCve27iabtlD2qr2jvX_Nv84k-6Fn8d76sJAlkyUfM5nJzuQ3AK-qBAshlDupSrQUrRQ0s4pTg047aWs0BiSm4WG6e4T7YzFegV_dXRgfVtntiWGjNhPt_5FvceWhQ9IU5ZZtwyK-7gw-nP-gPoOU97R26TQaFjmo5pfu-Hbxfm_HrfXrOB58Gm3v0jbDANWCJVNalrxQRWadjraxFomVtqoQrVaOr5XGLDVSWSeCJlYlE4pjYVXGquAu00Yl7ru34LZMBPcyJsf9YY8pDInaWIKMikRg51FlDYAp9yFzKXXqVdL5ok68Zuhej9f8x2kbdOHgLqy3Riz52HDdPVip6vuwNmzd9A9gf-RzhR2TiSX-kqSnDbiZvlDUhhRXoXjmOkNOazL89o4U7s2nTpqZQP5le0QC8u1DOLqRKX0Eq_Wkrp4AkVKWmTRxapXBTPIyzjgaxjUyVSqdRcC6act1i2juE2uc5T0Wc5jp3Eex-ZnO5xG86ZucN3Aey4g3u7XIW8m-yP_wYQQv-2onk97RUtTVZBZouL8iLJbTKGc7YppG8LhZ3r5HsXTN3ROBXFj4nsBjgi_W1KcnARscnbnLJYvgbccif3X9fwPdWD7QF7DmRC3_vHd48BTuxJ5vQ7zyJqxOf86qZ84qm5bPA_sT-H7T8vYbKTdFmA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Timing+of+retinal+neuronal+and+axonal+loss+in+MS%3A+a+longitudinal+OCT+study&rft.jtitle=Journal+of+neurology&rft.au=Balk%2C+Lisanne+J.&rft.au=Cruz-Herranz%2C+Andr%C3%A9s&rft.au=Albrecht%2C+Philipp&rft.au=Arnow%2C+Sam&rft.date=2016-07-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0340-5354&rft.eissn=1432-1459&rft.volume=263&rft.issue=7&rft.spage=1323&rft.epage=1331&rft_id=info:doi/10.1007%2Fs00415-016-8127-y&rft.externalDocID=10_1007_s00415_016_8127_y |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-5354&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-5354&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-5354&client=summon |